These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 24682843)

  • 1. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation.
    Stefanini GG; Stortecky S; Cao D; Rat-Wirtzler J; O'Sullivan CJ; Gloekler S; Buellesfeld L; Khattab AA; Nietlispach F; Pilgrim T; Huber C; Carrel T; Meier B; Jüni P; Wenaweser P; Windecker S
    Eur Heart J; 2014 Oct; 35(37):2530-40. PubMed ID: 24682843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of coronary artery disease in patients undergoing transfemoral transcatheter aortic valve implantation.
    Shamekhi J; Stundl A; Weber M; Mellert F; Welz A; Grube E; Nickenig G; Werner N; Sinning JM
    Int J Cardiol; 2017 Oct; 245():215-221. PubMed ID: 28789844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of coronary artery disease severity and revascularization completeness on 2-year clinical outcomes in patients undergoing transcatether aortic valve replacement.
    Witberg G; Lavi I; Harari E; Shohat T; Orvin K; Codner P; Vaknin-Assa H; Assali A; Kornowski R
    Coron Artery Dis; 2015 Nov; 26(7):573-82. PubMed ID: 26180996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
    Huczek Z; Zbroński K; Grodecki K; Scisło P; Rymuza B; Kochman J; Dąbrowski M; Witkowski A; Wojakowski W; Parma R; Ochała A; Grygier M; Olasińska-Wiśniewska A; Araszkiewicz A; Jagielak D; Ciećwierz D; Puchta D; Paczwa K; Filipiak KJ; Wilimski R; Zembala M; Opolski G
    Catheter Cardiovasc Interv; 2018 Jan; 91(1):115-123. PubMed ID: 28843025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes and revascularization strategies in patients with low-flow, low-gradient severe aortic valve stenosis according to the assigned treatment modality.
    O'Sullivan CJ; Englberger L; Hosek N; Heg D; Cao D; Stefanini GG; Stortecky S; Gloekler S; Spitzer E; Tüller D; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Carrel T; Meier B; Windecker S; Wenaweser P
    JACC Cardiovasc Interv; 2015 Apr; 8(5):704-17. PubMed ID: 25946444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve Replacement.
    Paradis JM; White JM; Généreux P; Urena M; Doshi D; Nazif T; Hahn R; George I; Khalique O; Harjai K; Lasalle L; Labbé BM; DeLarochellière R; Doyle D; Dumont É; Mohammadi S; Leon MB; Rodés-Cabau J; Kodali S
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Value of the SYNTAX Score II in Predicting Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation.
    Ryan N; Nombela-Franco L; Jiménez-Quevedo P; Biagioni C; Salinas P; Aldazábal A; Cerrato E; Gonzalo N; Del Trigo M; Núñez-Gil I; Fernández-Ortiz A; Macaya C; Escaned J
    Rev Esp Cardiol (Engl Ed); 2018 Aug; 71(8):628-637. PubMed ID: 29191780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter aortic valve implantation combined with elective coronary artery stenting: a simultaneous approach†.
    Penkalla A; Pasic M; Drews T; Buz S; Dreysse S; Kukucka M; Mladenow A; Hetzer R; Unbehaun A
    Eur J Cardiothorac Surg; 2015 Jun; 47(6):1083-9. PubMed ID: 25217500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation.
    Wenaweser P; Pilgrim T; Guerios E; Stortecky S; Huber C; Khattab AA; Kadner A; Buellesfeld L; Gloekler S; Meier B; Carrel T; Windecker S
    EuroIntervention; 2011 Sep; 7(5):541-8. PubMed ID: 21930453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice.
    Van Mieghem NM; van der Boon RM; Faqiri E; Diletti R; Schultz C; van Geuns RJ; Serruys PW; Kappetein AP; van Domburg RT; de Jaegere PP
    JACC Cardiovasc Interv; 2013 Aug; 6(8):867-75. PubMed ID: 23871511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of extent of coronary artery disease and percutaneous revascularization assessed by the SYNTAX score on outcomes following transcatheter aortic valve replacement.
    Stephan T; Thoma E; Rattka M; Felbel D; Buckert D; Rottbauer W; Gonska B; Markovic S
    BMC Cardiovasc Disord; 2021 Nov; 21(1):568. PubMed ID: 34847875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognostic Effects of Coronary Disease Severity and Completeness of Revascularization on Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Witberg G; Regev E; Chen S; Assali A; Barbash IM; Planer D; Vaknin-Assa H; Guetta V; Vukasinovic V; Orvin K; Danenberg HD; Segev A; Kornowski R
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1428-1435. PubMed ID: 28728656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Coronary Artery Disease on Postoperative Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR): Is Preoperative Coronary Revascularization Necessary?
    Chauhan D; Thawabi M; Haik N; Haik BJ; Chen C; Cohen M; Russo M
    J Invasive Cardiol; 2016 Dec; 28(12):E179-E184. PubMed ID: 27922809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation.
    Costa G; Pilgrim T; Amat Santos IJ; De Backer O; Kim WK; Barbosa Ribeiro H; Saia F; Bunc M; Tchetche D; Garot P; Ribichini FL; Mylotte D; Burzotta F; Watanabe Y; De Marco F; Tesorio T; Rheude T; Tocci M; Franzone A; Valvo R; Savontaus M; Wienemann H; Porto I; Gandolfo C; Iadanza A; Bortone AS; Mach M; Latib A; Biasco L; Taramasso M; Zimarino M; Tomii D; Nuyens P; Sondergaard L; Camara SF; Palmerini T; Orzalkiewicz M; Steblovnik K; Degrelle B; Gautier A; Del Sole PA; Mainardi A; Pighi M; Lunardi M; Kawashima H; Criscione E; Cesario V; Biancari F; Zanin F; Joner M; Esposito G; Adam M; Grube E; Baldus S; De Marzo V; Piredda E; Cannata S; Iacovelli F; Andreas M; Frittitta V; Dipietro E; Reddavid C; Strazzieri O; Motta S; Angellotti D; Sgroi C; Kargoli F; Tamburino C; Barbanti M;
    Circ Cardiovasc Interv; 2022 Dec; 15(12):e012417. PubMed ID: 36538579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation.
    Saia F; Palmerini T; Compagnone M; Battistini P; Moretti C; Taglieri N; Marcelli C; Bruno AG; Ghetti G; Corsini A; Bacchi Reggiani ML; Marrozzini C; Rapezzi C
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):19-27. PubMed ID: 30916884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation.
    Dewey TM; Brown DL; Herbert MA; Culica D; Smith CR; Leon MB; Svensson LG; Tuzcu M; Webb JG; Cribier A; Mack MJ
    Ann Thorac Surg; 2010 Mar; 89(3):758-67; discussion 767. PubMed ID: 20172123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Coronary Revascularization in Patients Who Underwent Transcatheter Aortic Valve Implantation.
    López Otero D; Ávila-Carrillo A; González Ferreiro R; Cid Menéndez A; Iglesias Álvarez D; Álvarez Rodríguez L; Antúnez Muiños P; Álvarez BC; Sanmartín Pena XC; Gómez Pérez F; Diéguez AR; Cruz-González I; Trillo Nouche R; González-Juanatey JR
    Am J Cardiol; 2019 Mar; 123(6):948-955. PubMed ID: 30598242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant coronary intervention is associated with poorer early and late clinical outcomes in selected elderly patients receiving transcatheter aortic valve implantation.
    Griese DP; Reents W; Tóth A; Kerber S; Diegeler A; Babin-Ebell J
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):e1-7. PubMed ID: 24819362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study.
    Barbanti M; Buccheri S; Capodanno D; D'Errigo P; Ranucci M; Rosato S; Santoro G; Fusco D; Tamburino C; Biancari F; Seccareccia F;
    Int J Cardiol; 2018 Nov; 270():102-106. PubMed ID: 29903519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incomplete Functional Revascularization Is Associated With Adverse Clinical Outcomes After Transcatheter Aortic Valve Implantation.
    Scarsini R; Venturi G; Pighi M; Lunardi M; Kotronias R; Del Sole PA; Rubino F; Tavella D; Pesarini G; Banning A; Ribichini F
    Cardiovasc Revasc Med; 2022 Sep; 42():47-52. PubMed ID: 35272945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.